Nanomedicine-nanotechnology Biology And Medicine

Nanomedicine-nanotechnology Biology And Medicine

纳米医学-纳米技术生物学与医学

  • 2区 中科院分区
  • Q2 JCR分区

期刊简介

《Nanomedicine-nanotechnology Biology And Medicine》是由Elsevier Inc.出版社于2005年创办的英文国际期刊(ISSN: 1549-9634,E-ISSN: 1549-9642),该期刊长期致力于医学:研究与实验领域的创新研究,主要研究方向为工程技术-纳米科技。作为SCIE收录期刊(JCR分区 Q2,中科院 2区),本刊采用OA未开放获取模式(OA占比0.0886...%),以发表医学:研究与实验领域等方向的原创性研究为核心(研究类文章占比96.05%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在76篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Nanomedicine-nanotechnology Biology And Medicine审稿周期约为 约6.0个月 约8.9周。该刊近年未被列入国际预警名单,年发文量约76篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 76 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 NANOSCIENCE & NANOTECHNOLOGY 纳米科技
3区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 NANOSCIENCE & NANOTECHNOLOGY 纳米科技
2区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 60 / 189

68.5%

学科:NANOSCIENCE & NANOTECHNOLOGY SCIE Q2 64 / 140

54.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 54 / 189

71.69%

学科:NANOSCIENCE & NANOTECHNOLOGY SCIE Q2 44 / 140

68.93%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:11.1 SJR:0.863 SNIP:0.743
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q1 12 / 183

93%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Medicine (miscellaneous) Q1 28 / 398

93%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Biomedical Engineering Q1 35 / 303

88%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:General Materials Science Q1 66 / 463

85%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Bioengineering Q1 27 / 162

83%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q1 30 / 178

83%

期刊发文

  • CXCL10-coronated thermosensitive ?stealth? liposomes for sequential chemoimmunotherapy in melanoma

    Author: Xin, Xiaofei; Zhou, Yong; Li, Jingjing; Zhang, Kai; Qin, Chao; Yin, Lifang

    Journal: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2023; Vol. 48, Issue , pp. -. DOI: 10.1016/j.nano.2022.102634

  • Bioinspired low-density lipoprotein co-delivery system for targeting and synergistic cancer therapy

    Author: Zhu, Qiaoling; Wang, Yajie; Huang, Ying; Zi, Yixuan; Yan, Simin; Shi, Xianbiao; Cai, Jun; Zhang, Haixia; Sang, Jianfeng; Zhang, Wenli; Ge, Weihong

    Journal: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2023; Vol. 48, Issue , pp. -. DOI: 10.1016/j.nano.2022.102641

  • Isolation-free measurement of single urinary extracellular vesicles by imaging flow cytometry

    Author: Wu, Liang; Woud, Wouter W.; Baan, Carla C.; Hesselink, Dennis A.; van der Pol, Edwin; Jenster, Guido; Boer, Karin

    Journal: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2023; Vol. 48, Issue , pp. -. DOI: 10.1016/j.nano.2022.102638

  • VEGF loaded nanofiber membranes inhibit chronic cerebral hypoperfusion-induced cognitive dysfunction by promoting HIF-1a/VEGF mediated angiogenesis

    Author: Wu, Yi-Fang; Jin, Kai-Yan; Wang, Da-Peng; Lin, Qi; Sun, Jun; Su, Shao-Hua; Hai, Jian

    Journal: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2023; Vol. 48, Issue , pp. -. DOI: 10.1016/j.nano.2022.102639

  • Cell membrane-camouflaged liposomes and neopeptide-loaded liposomes with TLR agonist R848 provides a prime and boost strategy for efficient personalized cancer vaccine therapy

    Author: Shi, Lu; Gu, Hongchen

    Journal: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2023; Vol. 48, Issue , pp. -. DOI: 10.1016/j.nano.2022.102648

  • Incorporation of glycyrrhizic acid and polyene phosphatidylcholine in lipid nanoparticles ameliorates acute liver injury via delivering p65 siRNA

    Author: Yin, Qiming; Song, Xiang; Yang, Peng; Yang, Wen; Li, Xinyu; Wang, Xuejun; Wang, Shengqi

    Journal: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2023; Vol. 48, Issue , pp. -. DOI: 10.1016/j.nano.2022.102649

  • PASylation improves pharmacokinetic of liposomes and attenuates anti-PEG IgM production: An alternative to PEGylation

    Author: Zhang, Qianyu; Li, Sai; Wu, Wen; Xia, Xuefeng; Zhang, Jinqiang

    Journal: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2023; Vol. 47, Issue , pp. -. DOI: 10.1016/j.nano.2022.102622

  • Original nanomedjournal.com Novel fabrication of bioengineered injectable chitosan hydrogel loaded with conductive nanoparticles to improve therapeutic potential of mesenchymal stem cells in functional recovery after ischemic myocardial infarction

    Author: Wu, Zheng; Li, Wenzheng; Cheng, Shujuan; Liu, Jinghua; Wang, Shaoping

    Journal: NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2023; Vol. 47, Issue , pp. -. DOI: 10.1016/j.nano.2022.102616